Results 91 to 100 of about 12,483,860 (378)
Autoantibodies to tumor-associated antigens as biomarkers in human hepatocellular carcinoma (HCC)
Tumor-associated antigens (TAAs) recognized by cellular and/or humoral effectors of the immune system are attractive targets for diagnostic and therapeutic approaches to human cancer.
L. Dai, Ning-Jing Lei, Mei Liu, J. Zhang
semanticscholar +1 more source
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura +19 more
wiley +1 more source
Since intracellular proteins involved in carcinogenesis have been shown to provoke autoantibody responses, autoantibodies can be used as probes in immunoproteomics to isolate, identify, and characterize potential tumor-associated antigens (TAAs).
Qing Zhu +7 more
semanticscholar +1 more source
Mechanisms and therapeutic opportunities of the ribotoxic stress response in cancer
Cancer cells' high translational demand creates opportunities to therapeutically target ribosome function. Ribosome stalling and collisions activate ZAKα and the ribotoxic stress response (RSR), which can trigger rapid, p53‐independent apoptosis in cancer.
Anastassiya Kim +7 more
wiley +1 more source
Monoclonal antibodies against human astrocytomas and their reactivity pattern [PDF]
The establishment of hybridomas after fusion of X63-Ag8.653 mouse myeloma cells and splenocytes from mice hyperimmunized against human astrocytomas is presented. The animals were primed with 5 × 106 chemically modified uncultured or cultured glioma cells.
Eisenmenger, Wolfgang +8 more
core +1 more source
This study integrates publicly available transcriptomic datasets to identify molecular signatures associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. By analyzing a combination of multiple cohorts with bioinformatics approaches, we reveal biological pathways and immune‐related features that may improve ...
Aleksandra Stanojevic +10 more
wiley +1 more source
Promising tumor-associated antigens for future prostate cancer therapy
Prostate cancer (CaP) is one of the most prevalent malignant diseases among men in Western countries. There is currently no cure for metastatic castrate-resistant CaP, and median survival for these patients is about 18 months; the high mortality rate ...
Cozzi, Paul +7 more
core +1 more source
Novel Strategies for Peptide-Based Vaccines in Hematological Malignancies
Peptides vaccination is an interesting approach to activate T-cells toward desired antigens in hematological malignancies. In addition to classical tumor associated antigens, such as cancer testis antigens, new potential targets for peptide vaccination ...
Uffe Klausen +11 more
doaj +1 more source
Autoantibodies targeting tumor-associated antigens in metastatic cancer
In addition to the well-established effector functions of IgGs, including direct cytotoxicity and antibody-dependent cellular cytotoxicity, some populations of IgGs may exert anti-inflammatory effects.
M. Oaks, Samuel J. Taylor, James Shaffer
semanticscholar +1 more source
Hypertonicity Induction of Melanoma Antigen, a Tumor-associated Antigen
Melanoma antigen (MAGE), a tumor-associated antigen, is a product of members of a gene family that consist of 24 structurally related genes. MAGE genes are expressed only in the testis among normal tissues, but they are also expressed in a number of human tumors of various histological types.
Joo-Hung, Park, Soo-Woong, Lee
openaire +2 more sources

